Brucellosis in the Middle East: A persistent medical, socioeconomic and political issue

Journal of Chemotherapy

Volumn 19, Issue 3, 2007, Pages 243-248

  Pappas, G ^a   Memish, Z A ^b,c,d,e,f  

^a Institute of Continuing Medical Education of Ioannina   (Greece)

^b KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

^c Gulf Cooperation Council (States) Centre for Infection Control   (Saudi Arabia)

^d Infection Prevention and Control Program   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f University of Ottawa ^*  (Saudi Arabia)

Author keywords

Brucellosis; Infectious disease; Middle Eastern infectious disease

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN;

BACTERIUM DETECTION; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SUBSTITUTION; ENDEMIC DISEASE; ENDOCARDITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; MIDDLE EAST; POLITICS; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SOCIOECONOMICS;

EID: 34447548560     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.3.243     Document Type: Review

References (27)

1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91-9.
2. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352:2325-36.
3. Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med. 2004;11:49-55.
4. Elbeltagy KE. An epidemiological profile of brucellosis in Tabuk Province, Saudi Arabia. East Mediterr Health J. 2001;7:791-8.
5. Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet. 2006;367:1008-15.
6. Bilal NE, Jamjoom GA, Bobo RA, Aly OF, el-Nashar NM. A study of the knowledge, attitude and practice (KAP) of a Saudi Arabian community towards the problem of brucellosis. J Egypt Public Health Assoc. 1991;66:227-38.
7. The MCZP Report on the Third Workshop on Human and Animal Brucellosis Epidemiological Surveillance in the MCZP Countries. Available at www.mzcp-zoonoses.gr/pdfen/Brucellosis.pdf, last accessed May 24, 2006.
8. Ahmad R, Munir MI. Epidemiological investigation of brucellosis in Pakistan. Pakistan Vet J 1995;15:169-72.
9. Husseini AS, Ramlawi AM. Brucellosis in the West Bank, Palestine. Saudi Med J. 2004;25:1640-3.
10. Almuneef MA, Memish ZA, Balkhy HH, Alotaibi B, Algoda S, Abbas M, et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect. 2004;132:533-40.
11. Shaalan MA, Memish ZA, Mahmoud SA, Alomari A, Khan MY, Almuneef M, et al. Brucellosis in children: clinical observations in 115 cases. Int J Infect Dis. 2002;6:182-6.
12. Lubani MM, Dudin KI, Sharda DC, Ndhar DS, Araj GF, Hafez HA, et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. 1989;8:75-8.
13. Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis. 2001;32:1172-7.
14. Memish ZA, Mah MW, Al Mahmoud S, Al Shaalan M. Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect. 2000;40:59-63.
15. Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM, Soleimani Amiri MJ, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect. 2004;132:1109-14.
16. Lulu AR, Araj GF, Khateeb Ml, Mustafa MY, Yusuf AR, Fenech FF. Human brucellosis in Kuwait: a prospective study of 400 cases. Quart J Med. 1988;66:39-54.
17. Al-Shamahy HA, Wright SG. A study of 235 cases of human brucellosis in Sana'a. Republic of Yemen. East Mediterr Health J. 2001;7:238-46.
18. Alsoub H. Brucella infective endocarditis: a report of four successfully treated patients. Clin Microbiol Infect. 2001;7:382-5.
19. Memish ZA, Mah MW. Brucellosis in laboratory workers at a Saudi Arabian hospital. Am J Infect Control. 2001;29:48-52.
20. Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO. Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia. Diagn Microbiol Infect Dis. 2002;44:129-32.
21. Ismail TF, Smits H, Wasfy MO, Malone JL, Fadeel MA. Mahoney F. Evaluation of dipstick serologic tests for diagnosis of brucellosis and typhoid fever in Egypt. J Clin Microbiol. 2002;40:3509-11.
22. Hasanjani Roushan MR, Mohraz M, Hajiahmadi M. Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis. 2006;42:1075-80.
23. Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF, Alzeer HA. Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology. 2001;6:317-22.
24. Roushan MR, Gangi SM, Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly. 2004;134:564-8.
25. Bannatyne RM, Rich M, Memish ZA. Co-trimoxazole resistant brucella. J Trop Pediatr. 2001;47:60.
26. Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother. 2006;50:22-33
27. Pappas G, Christou L, Akritidis N, Tsianos EV. Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect. 2006;12:823-5.